Prof. Dr. Luitpold Distel



Organisation


Strahlenklinik
Medizinische Fakultät
Einrichtungen, die zum Universitätsklinikum Erlangen gehören


Publications (Download BibTeX)

Go to first page Go to previous page 1 of 7 Go to next page Go to last page

Jost, T., Hecht, M., Fietkau, R., & Distel, L. (2019). Influence of the Kinase Inhibitor Palbociclib on the Migration of malignant and non-malignant Cells under Irradiation. In STRAHLENTHERAPIE UND ONKOLOGIE (pp. S171-S171). Munster, GERMANY: HEIDELBERG: SPRINGER HEIDELBERG.
Stritzelberger, J., Distel, L., Buslei, R., Fietkau, R., & Putz, F. (2018). Acquired temozolomide resistance in human glioblastoma cell line U251 is caused by mismatch repair deficiency and can be overcome by lomustine. Clinical & Translational Oncology, 20(4), 508-516. https://dx.doi.org/10.1007/s12094-017-1743-x
Klein, S., Wegmann, M., Distel, L., Neuhuber, W., & Kryschi, C. (2018). APTES-Terminated ultrasmall and iron-doped silicon nanoparticles as X-Ray dose enhancer for radiation therapy. Biochemical and Biophysical Research Communications, 498(4), 855-861. https://dx.doi.org/10.1016/j.bbrc.2018.03.070
Hoffmann, C., Distel, L., Knippen, S., Gryc, T., Schmidt, M., Fietkau, R., & Putz, F. (2018). Brain volume reduction after whole-brain radiotherapy: quantification and prognostic relevance. Neuro-Oncology, 20(2), 268-278. https://dx.doi.org/10.1093/neuonc/nox150
Hecht, M., Meier, F., Zimmer, L., Polat, B., Loquai, C., Weishaupt, C.,... Heinzerling, L. (2018). Clinical outcome of concomitant vs interrupted BRAF inhibitor therapy during radiotherapy in melanoma patients. British Journal of Cancer, 118(6), 785-792. https://dx.doi.org/10.1038/bjc.2017.489
Hecht, M., Harrer, T., Koeber, V., Sarpong, E.O., Moser, F., Fiebig, N.,... Distel, L. (2018). Cytotoxic effect of Efavirenz in BxPC-3 pancreatic cancer cells is based on oxidative stress and is synergistic with ionizing radiation. Oncology Letters, 15(2), 1728-1736. https://dx.doi.org/10.3892/ol.2017.7523
Jost, T., Hecht, M., Fietkau, R., & Distel, L. (2018). Effect of the kinase-inhibitor Palbociclib on radio-therapeutic treatment in a 3D cell culture model. (pp. 46-46).
Klein, S., Kizaloglu, M., Portilla Berlanga, L., Park, H., Rejek, T., Hümmer, J.,... Kryschi, C. (2018). Enhanced In Vitro Biocompatibility and Water Dispersibility of Magnetite and Cobalt Ferrite Nanoparticles Employed as ROS Formation Enhancer in Radiation Cancer Therapy. Small. https://dx.doi.org/10.1002/smll.201704111
Pröbstle, S., Jost, T., Buerkel, F., Hecht, M., Fietkau, R., & Distel, L. (2018). Enhancing the Effect of Combination Therapy with the PARP Inhibitor Talazoparib and ionizing Radiation on Melanoma Cell Lines. (pp. S171-S171).
Wehrhan, F., Büttner-Herold, M., Distel, L., Ries, J., Möbius, P., Preidl, R.,... Weber, M. (2018). Galectin 3 expression in regional lymph nodes and lymph node metastases of oral squamous cell carcinomas. BMC Cancer, 18(1). https://dx.doi.org/10.1186/s12885-018-4726-6

Last updated on 2017-15-10 at 02:01